Another big-ticket global acquisition by an Indian company is brewing. United Phosphorus and Tata Group enterprise Rallis India are in the race to acquire the world’s largest privately held crop protection and life sciences firm, Arysta LifeScience Corporation, from private equity firm Olympus Capital Holdings.
Sources close to the development said these two Indian companies were among the six contenders for the Tokyo-based firm. The acquisition is expected to cost nearly $2 billion (Rs 8,200 crore), or nearly double Arysta's turnover of 124.1 billion yen (Rs 4,400 crore) last year.
Other bidders include an Israeli firm, Australia’s Nufarm and Blackstone, the global private equity fund.
Olympus has put Arysta on the block and has appointed investment banks Goldman Sachs and Lehman Brothers for the sale. It had bought 8.7 per cent of Arysta in 2002 for around $80 million (Rs 320 crore). Since then, it has been gradually building up its stake.
(Source: Business Standard)
Showing posts with label Life Sciences. Show all posts
Showing posts with label Life Sciences. Show all posts
Tuesday, September 11, 2007
Tuesday, July 24, 2007
Patni Acquires Life Sciences Services Company Taratec for $27 million
Patni Computer Systems, a global IT services provider, announced the acquisition of Bridgewater, N.J.-based Taratec Development Corp. through Patni Computer Systems Inc. a wholly owned subsidiary of the Company, for an aggregate price of $27.2 million in cash including contingent consideration. With more than $20m in annual revenues, Taratec is a leading consulting company in the life sciences industry providing integrated business, information technology, and regulatory compliance products and services.
This acquisition is in line with Patni’s strategy of enhancing its market specific services and provides additional capability to support thegrowing and diverse requirements of the Life Sciences market, from pharmacovigilance to demand-driven supply chains. Patni can now offera global delivery model that provides end-to-end capabilities complete with established, life science expertise in specific, high-demand areas
(Source: Patni Press Release)
This acquisition is in line with Patni’s strategy of enhancing its market specific services and provides additional capability to support thegrowing and diverse requirements of the Life Sciences market, from pharmacovigilance to demand-driven supply chains. Patni can now offera global delivery model that provides end-to-end capabilities complete with established, life science expertise in specific, high-demand areas
(Source: Patni Press Release)
Subscribe to:
Posts (Atom)
